Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 1
2008 1
2009 3
2010 3
2011 3
2012 4
2013 1
2015 5
2016 9
2017 6
2018 5
2019 5
2020 2
2021 8
2022 5
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Richardson PG, Oriol A, Larocca A, Bladé J, Cavo M, Rodriguez-Otero P, Leleu X, Nadeem O, Hiemenz JW, Hassoun H, Touzeau C, Alegre A, Paner A, Maisel C, Mazumder A, Raptis A, Moreb JS, Anderson KC, Laubach JP, Thuresson S, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Mateos MV; HORIZON (OP-106) Investigators. Richardson PG, et al. Among authors: raptis a. J Clin Oncol. 2021 Mar 1;39(7):757-767. doi: 10.1200/JCO.20.02259. Epub 2020 Dec 9. J Clin Oncol. 2021. PMID: 33296242 Free PMC article. Clinical Trial.
Multifocal primary cutaneous nodular amyloidosis.
Matsumoto ME, Collins MK, Raptis A, Jedrych J, Patton T. Matsumoto ME, et al. Among authors: raptis a. Dermatol Online J. 2017 May 15;23(5):13030/qt9511r6bg. Dermatol Online J. 2017. PMID: 28537855 Free article. Review.
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Boyiadzis M, Bailey NG. Lontos K, et al. Among authors: raptis a. Leuk Lymphoma. 2023 Mar;64(3):750-752. doi: 10.1080/10428194.2023.2172981. Epub 2023 Feb 1. Leuk Lymphoma. 2023. PMID: 36722791 Free PMC article. No abstract available.
The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical care.
Bosserman L, Prendergast F, Herbst R, Fleisher M, Salom E, Strickland S, Raptis A, Hallquist A, Perree M, Rajurkar S, Karimi M, Rogers K, Davidson D, Willis C, Penalver M, Homesley H, Burrell M, Garrett A, Rutledge J, Chernick M, Presant CA. Bosserman L, et al. Among authors: raptis a. Cancer Res. 2012 Aug 15;72(16):3901-5. doi: 10.1158/0008-5472.CAN-12-0681. Epub 2012 Aug 3. Cancer Res. 2012. PMID: 22865459 Review.
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.
Quann K, Lontos K, Sehgal A, Raptis A, Im A, Redner RL, Dorritie KA, Agha M, Hou JZ, Farah R, Rossetti J, Normolle DP, Whiteside TL, Hsu YS, Boyiadzis M. Quann K, et al. Among authors: raptis a. Haematologica. 2024 Dec 1;109(12):4106-4111. doi: 10.3324/haematol.2024.285313. Haematologica. 2024. PMID: 39113675 Free PMC article. No abstract available.
Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
Roth CG, Gillespie-Twardy A, Marks S, Agha M, Raptis A, Hou JZ, Farah R, Lin Y, Qian Y, Pantanowitz L, Boyiadzis M. Roth CG, et al. Among authors: raptis a. Oncol Res. 2016;23(3):137-46. doi: 10.3727/096504015X14500972666761. Oncol Res. 2016. PMID: 26931436 Free PMC article.
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Im A, Quann K, Agha M, Raptis A, Redner RL, Hou JZ, Farah R, Dorritie KA, Sehgal AR, Normolle D, Bovbjerg DH, Aggarwal N, Herman J, Lontos K, Boyiadzis M. Im A, et al. Among authors: raptis a. Am J Hematol. 2024 Mar;99(3):380-386. doi: 10.1002/ajh.27212. Epub 2024 Jan 22. Am J Hematol. 2024. PMID: 38258329 Free PMC article. Clinical Trial.
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Gooding W, Boyiadzis M. Lontos K, et al. Among authors: raptis a. Leuk Lymphoma. 2022 Dec;63(13):3257-3260. doi: 10.1080/10428194.2022.2118532. Epub 2022 Sep 8. Leuk Lymphoma. 2022. PMID: 36075047 Free PMC article. No abstract available.
57 results